참고문헌
- Andersen S, Pedersen KM, Bruun NH, Laurberg P (2002). Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab, 87, 1068-72. https://doi.org/10.1210/jcem.87.3.8165
- Aoki Y, Belin RM, Clickner R, et al (2007). Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002). Thyroid, 17, 1211-23. https://doi.org/10.1089/thy.2006.0235
- Babu GR, Lakshmi SB, Thiyagarajan JA (2013). Epidemiological correlates of breast cancer in South India. Asian Pac J Cancer Prev, 14, 5077-83. https://doi.org/10.7314/APJCP.2013.14.9.5077
- Beex L, Ross A, Smals A, Kloppenborg P (1977). 5-fluorouracil- induced increase of total serum thyroxine and triiodothyronine. Cancer Treat Rep, 61, 1291-5.
- Chapman RM (1992). Gonadal toxicity and teratogenicity, In: Perry MC, editors. Chemotherapy Source Book, Williams Wilkins: Baltimore, 710-53.
- De Groot S, Janssen LGM, Charehbili A, et al (2015). Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01). Breast Cancer Res Treat, 149, 461-6. https://doi.org/10.1007/s10549-014-3256-4
- Del Ghianda S, Tonacchera M, Vitti P (2014). Thyroid and menopause. Climacteric, 17, 225-34. https://doi.org/10.3109/13697137.2013.838554
- Dong BJ (2000). How medications affect thyroid function. West J Med, 172, 102-6. https://doi.org/10.1136/ewjm.172.2.102
- Ferster A, Glinoer D, Van Vliet G, Otten J (1992). Thyroid function during L-asparaginase therapy in children with acute lymphoblastic leukemia: difference between induction and late intensification. Am J Pediatr Hematol Oncol, 14, 192-6. https://doi.org/10.1097/00043426-199208000-00002
- Fujiwara Y, Chayahara N, Mukohara T, et al (2013). Hypothyroidism in patients with colorectal carcinoma treated with fluoropyrimidines. Oncol Rep, 30, 1802-6. https://doi.org/10.3892/or.2013.2644
- Garnick MB, Larsen PR (1979). Acute deficiency of thyroxine binding globulin during L-asparaginase therapy. N Engl J Med, 301, 252-3. https://doi.org/10.1056/NEJM197908023010506
- Hamnvik OP, Larsen PR, Marqusee E (2011). Thyroid dysfunction from antineoplastic agents. J Natl Cancer Inst, 103, 1572-87. https://doi.org/10.1093/jnci/djr373
- Heidemann PH, Stubbe P, Beck W (1981). Transient secondary hypothyroidism and thyroxine binding globulin deficiency in leukemic children during polychemotherapy: an effect of L-asparaginase. Eur J Pediatr, 136, 291-5. https://doi.org/10.1007/BF00442997
- Hellevik AI, Asvold BO, Bjoro T, et al (2009). Thyroid function and cancer risk: a prospective population study. Cancer Epidemiol Biomarkers Prev, 18, 570-4. https://doi.org/10.1158/1055-9965.EPI-08-0911
- Hollowell JG, Staehling NW, Flanders WD, et al (2002). Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab, 87, 489-99. https://doi.org/10.1210/jcem.87.2.8182
- Huang J, Jin L, Ji G, et al (2013). Implication from thyroid function decreasing during chemotherapy in breast cancer patients: chemosensitization role of triiodothyronine. BMC Cancer, 13, 334. https://doi.org/10.1186/1471-2407-13-334
- Khan NF, Mant D, Carpenter L, Forman D, Rose PW (2011). Long-term health outcomes in a British cohort of breast, colorectal and prostate cancer survivors: a database study. Br J Cancer, 105, 29-37. https://doi.org/10.1038/bjc.2011.420
- LeGrys VA, Funk MJ, Lorenz CE, et al (2013). Subclinical hypothyroidism and risk for incident myocardial infarction among postmenopausal women. J Clin Endocrinol Metab, 98, 2308-17. https://doi.org/10.1210/jc.2012-4065
- Mamby CC, Love RR, Lee KE (1995). Thyroid function test changes with adjuvant tamoxifen therapy in postmenopausal women with breast cancer. J Clin Oncol, 13, 854-7. https://doi.org/10.1200/JCO.1995.13.4.854
- Massart C, Le Tellier C, Lucas C, et al (1992). Effects of cisplatin on human thyrocytes in monolayer or follicle culture. J Mol Endocrinol, 8, 243-8. https://doi.org/10.1677/jme.0.0080243
- Meistrich ML,Vassilopoulou-Sellin R, Lipshultz LI (1997). Adverse effects of treatment: gonadal dysfunction. In: DeVita VT, Hellman S, Rosenberg SA, editors. cancer, principles and practice of oncology, ed 5, New York: Lippincott-Raven Publishers, 2758-73.
- Stuart NS, Woodroffe CM, Grundy R, Cullen MH (1990). Longterm toxicity of chemotherapy for testicular cancer-the cost of cure. Br J Cancer, 61, 479-84. https://doi.org/10.1038/bjc.1990.106
- Surks MI, Sievert R (1995). Drugs and thyroid function. N Engl J Med, 333, 1688-94. https://doi.org/10.1056/NEJM199512213332507
- Sutcliffe SB, Chapman R, Wrigley PF (1981). Cyclical combination chemotherapy and thyroid function in patients with advanced Hodgkin's disease. Med Pediatr Oncol, 9, 439-48. https://doi.org/10.1002/mpo.2950090505
- Torino F, Barnabei A, Paragliola R, et al (2013). Thyroid dysfunction as an unintended side effect of anticancer drugs. Thyroid, 23, 1345-66. https://doi.org/10.1089/thy.2013.0241
- Tosovic A, Bondeson AG, Bondeson L, Ericsson UB, Manjer J (2013). Triiodothyronine levels in relation to mortality from breast cancer and all causes: a population-based prospective cohort study. Eur J Endocrinol, 168, 483-90. https://doi.org/10.1530/EJE-12-0564
- Tosovic A, Becker C, Bondeson AG, et al (2012). Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to breast cancer risk. Int J Cancer, 131, 2126-33. https://doi.org/10.1002/ijc.27470
- Varughese AA, Poothiode U, Manjula VD (2015). Descriptive study on selected risk factors and histopathology of breast carcinoma in a tertiary care centre in kerala, indiawith special reference to women under 40 years old. Asian Pac J Cancer Prev, 16, 181-4. https://doi.org/10.7314/APJCP.2015.16.1.181
- Warner MH, Beckett GJ (2010). Mechanisms behind the nonthyroidal illness syndrome: an update. J Endocrinol, 205, 1-13. https://doi.org/10.1677/JOE-09-0412
- Yeung SCJ, Chiu AC, Vassilopoulou-Sellin R, Gagel RF (1998). The endocrine effects of nonhormonal antineoplastic therapy. Endocrine Rev, 19, 144-72. https://doi.org/10.1210/edrv.19.2.0328
피인용 문헌
- Early manifestation of mild cognitive impairment in B-cell non-Hodgkin’s lymphoma patients receiving CHOP and rituximab-CHOP chemotherapy vol.389, pp.12, 2016, https://doi.org/10.1007/s00210-016-1290-y